MOG (35-55), mouse, rat

Overview

MOG (35-55), mouse, rat is a pivotal peptide recognized for its role in inducing autoantibody production and mimicking the effects of relapsing-remitting neurological disease. This peptide is derived from myelin oligodendrocyte glycoprotein, a crucial component expressed in the central nervous system. Notably, MOG (35-55) has been associated with extensive plaque-like demyelination, providing significant insights into multiple sclerosis (MS) and other related conditions.

Key Features

• Induces autoantibody production related to neurological diseases
• Relevance to multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
• Used in research with C57/BL6 mice and Lewis rats
• High purity and quality for reliable experimental results
• Available for research purposes in various formats

Specifications

FAQ

What is MOG (35-55)?

MOG (35-55) is a peptide derived from myelin oligodendrocyte glycoprotein, known for its role in inducing autoimmune responses related to neurological diseases.

How is MOG (35-55) used in research?

This peptide is primarily used in studies related to multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) in animal models, including C57/BL6 mice and Lewis rats.

What type of experiments can benefit from MOG (35-55)?

Researchers investigating demyelination processes and autoimmune responses in the central nervous system can use MOG (35-55) to better understand the mechanisms involved in neurological disorders.

Don’t miss out on the opportunity to enhance your research with MOG (35-55). Browse our selection of other peptides to complement your studies, such as Autocamtide-2 and CREBtide. Each lot is carefully tested to ensure the highest quality, helping you achieve meaningful results in your experiments.

Related Products

• PKG Substrate [RKRSRAE], Glasstide

Browse more in Peptides.